IL67829A - Propylamine and allylamine derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

Propylamine and allylamine derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number: IL67829A
Authority: IL; Israel
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; propylamine; hydrogen
Prior art date: 1982-02-04

Application number

IL67829A

Other languages

English (en)

Other versions

IL67829A0 (en

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-04

Filing date

1983-02-03

Publication date

1988-06-30

1983-02-03 Application filed by Wellcome Found filed Critical Wellcome Found

1983-02-03 Priority to IL78419A priority Critical patent/IL78419A/xx

1983-06-15 Publication of IL67829A0 publication Critical patent/IL67829A0/xx

1986-04-03 Priority to IL78419A priority patent/IL78419A0/xx

1988-06-30 Publication of IL67829A publication Critical patent/IL67829A/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 title 2
VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical class NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 title 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
206010027654 Allergic conditions Diseases 0.000 abstract 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
238000002636 symptomatic treatment Methods 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000004423 acyloxy group Chemical group 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
150000001408 amides Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Superconductors And Manufacturing Methods Therefor (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Polyesters Or Polycarbonates (AREA)
Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

IL67829A 1982-02-04 1983-02-03 Propylamine and allylamine derivatives,their preparation and pharmaceutical compositions containing them IL67829A (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
IL78419A IL78419A (en)	1982-02-04	1983-02-03	Derivatives of diphenylmethane and pyridylphenylmethane
IL78419A IL78419A0 (en)	1982-02-04	1986-04-03	Intermediate compounds for the preparation of propylamine and allylamine derivatives

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8203261		1982-02-04
GB8229705		1982-10-18

Publications (2)

Publication Number	Publication Date
IL67829A0 IL67829A0 (en)	1983-06-15
IL67829A true IL67829A (en)	1988-06-30

Family

ID=26281898

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL67829A IL67829A (en)	1982-02-04	1983-02-03	Propylamine and allylamine derivatives,their preparation and pharmaceutical compositions containing them
IL78419A IL78419A (en)	1982-02-04	1983-02-03	Derivatives of diphenylmethane and pyridylphenylmethane
IL78419A IL78419A0 (en)	1982-02-04	1986-04-03	Intermediate compounds for the preparation of propylamine and allylamine derivatives

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
IL78419A IL78419A (en)	1982-02-04	1983-02-03	Derivatives of diphenylmethane and pyridylphenylmethane
IL78419A IL78419A0 (en)	1982-02-04	1986-04-03	Intermediate compounds for the preparation of propylamine and allylamine derivatives

Country Status (32)

Country	Link
EP (2)	EP0249950B1 (pt)
JP (2)	JPS6479153A (pt)
KR (6)	KR880001466B1 (pt)
AT (2)	ATE42282T1 (pt)
AU (1)	AU555083B2 (pt)
BG (6)	BG42004A3 (pt)
CA (2)	CA1249830A (pt)
CS (1)	CS235306B2 (pt)
CY (1)	CY1627A (pt)
DD (1)	DD209446A5 (pt)
DE (2)	DE3382321D1 (pt)
DK (1)	DK164662C (pt)
ES (6)	ES519491A0 (pt)
FI (1)	FI82450C (pt)
GB (1)	GB2114565B (pt)
GR (1)	GR77407B (pt)
HK (1)	HK25892A (pt)
HU (1)	HU189223B (pt)
IE (1)	IE54600B1 (pt)
IL (3)	IL67829A (pt)
MC (1)	MC1498A1 (pt)
NL (1)	NL930057I2 (pt)
NO (2)	NO162556C (pt)
NZ (1)	NZ203171A (pt)
PH (1)	PH21348A (pt)
PL (6)	PL140708B1 (pt)
PT (1)	PT76192B (pt)
SG (1)	SG106091G (pt)
SI (1)	SI8310221A8 (pt)
SU (1)	SU1301312A3 (pt)
UY (1)	UY23404A1 (pt)
YU (1)	YU44821B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4501893A (en) *	1982-02-04	1985-02-26	Findlay John W A	3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
US4610995A (en) *	1984-07-27	1986-09-09	Coker Geoffrey G	Certain 1,1-diaryl-propenyl-3-(1-pyrrolidino-2-carboxylic acids, derivatives thereof and their anti-histaminic properties
LU86387A1 (fr) *	1986-04-04	1987-12-07	Oreal	Composes aromatiques,leur procede de preparation et leur utilisation en medicine humaine et veterinaire et en cosmetique
GB8707416D0 (en) *	1987-03-27	1987-04-29	Wellcome Found	Pharmaceutical formulations
DE3711866A1 (de) *	1987-04-08	1988-10-27	Hoechst Ag	Synthese von peptidamiden mittels festphasenmethode unter verwendung von saeurelabilen ankergruppen
GB8914060D0 (en) *	1989-06-19	1989-08-09	Wellcome Found	Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
AU650421B2 (en) *	1989-06-19	1994-06-23	Wellcome Foundation Limited, The	Medicaments useful in cancer therapy and having antihistaminic properties
GB8914040D0 (en) *	1989-06-19	1989-08-09	Wellcome Found	Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
FR2711651B1 (fr) *	1993-10-28	1995-12-22	Adir	Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
US5420866A (en) *	1994-03-29	1995-05-30	Scientific-Atlanta, Inc.	Methods for providing conditional access information to decoders in a packet-based multiplexed communications system
GB9508748D0 (en) *	1995-04-28	1995-06-14	British Biotech Pharm	Benzimidazole derivatives
JPH11510180A (ja) *	1995-08-05	1999-09-07	ブリティッシュバイオテックファーマシューティカルズリミテッド	イミダゾピリジン誘導体
IT1277597B1 (it) *	1995-09-15	1997-11-11	Smithkline Beecham Spa	Derivati di diarilalchenilammina
JP2002212167A (ja) *	2001-01-22	2002-07-31	Nippon Nohyaku Co Ltd	ジアセチルピリジン誘導体の製造方法
CN101838235B (zh) *	2009-06-12	2013-08-07	重庆华邦制药有限公司	3-苯基-3＇-吡啶基丙烯胺类化合物及其合成方法
WO2012038521A1 (en) *	2010-09-23	2012-03-29	Syngenta Participations Ag	Novel microbiocides
EP2841534A2 (en)	2012-04-23	2015-03-04	Saudi Basic Industries Corporation	Solar energy based countinuous process and reactor system for the production of an alkene by dehydrogenation of the corresponding alkane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2567245A (en) *	1948-05-10	1951-09-11	Schering Corp	Aryl-(2-pyridyl)-amino alkanes and their production
DE1227464B (de) *	1951-09-10	1966-10-27	Wellcome Found	Verfahren zur Herstellung der trans-Form des neuen 1-(4'-Methylphenyl)-1-(2''-pyridyl)-3-pyrrolidinopropens-(1)
FR1228801A (fr) *	1954-05-03	1960-09-02	Farbwerke Hoechst Ag Vomals Me	Procédé de préparation de composés tertio-amino carboxyliques et des composés tertio-amino cétoniques correspondants
FR2197583B1 (pt) *	1972-09-07	1975-10-17	Rhone Poulenc Ind

1983
- 1983-02-01 YU YU221/83A patent/YU44821B/xx unknown
- 1983-02-01 SI SI8310221A patent/SI8310221A8/sl unknown
- 1983-02-03 PL PL1983240412A patent/PL140708B1/pl unknown
- 1983-02-03 ES ES519491A patent/ES519491A0/es active Granted
- 1983-02-03 PL PL1983245842A patent/PL140810B1/pl unknown
- 1983-02-03 HU HU83377A patent/HU189223B/hu unknown
- 1983-02-03 MC MC831619A patent/MC1498A1/fr unknown
- 1983-02-03 BG BG062834A patent/BG42004A3/xx unknown
- 1983-02-03 PH PH28475A patent/PH21348A/en unknown
- 1983-02-03 GB GB08302971A patent/GB2114565B/en not_active Expired
- 1983-02-03 DE DE8787108671T patent/DE3382321D1/de not_active Expired - Lifetime
- 1983-02-03 PL PL1983245844A patent/PL140812B1/pl unknown
- 1983-02-03 DE DE8383101036T patent/DE3379654D1/de not_active Expired
- 1983-02-03 EP EP87108671A patent/EP0249950B1/en not_active Expired - Lifetime
- 1983-02-03 FI FI830380A patent/FI82450C/fi not_active IP Right Cessation
- 1983-02-03 IL IL67829A patent/IL67829A/xx not_active IP Right Cessation
- 1983-02-03 AT AT83101036T patent/ATE42282T1/de active
- 1983-02-03 NZ NZ203171A patent/NZ203171A/en unknown
- 1983-02-03 PL PL1983245841A patent/PL140809B1/pl unknown
- 1983-02-03 AT AT87108671T patent/ATE64596T1/de not_active IP Right Cessation
- 1983-02-03 IL IL78419A patent/IL78419A/xx not_active IP Right Cessation
- 1983-02-03 CS CS83754A patent/CS235306B2/cs unknown
- 1983-02-03 PL PL1983245845A patent/PL141639B1/pl unknown
- 1983-02-03 GR GR70400A patent/GR77407B/el unknown
- 1983-02-03 PT PT76192A patent/PT76192B/pt unknown
- 1983-02-03 BG BG062833A patent/BG42003A3/xx unknown
- 1983-02-03 BG BG062836A patent/BG41822A3/xx unknown
- 1983-02-03 NO NO830368A patent/NO162556C/no not_active IP Right Cessation
- 1983-02-03 KR KR1019830000440A patent/KR880001466B1/ko not_active Expired
- 1983-02-03 PL PL1983245843A patent/PL140811B1/pl unknown
- 1983-02-03 IE IE213/83A patent/IE54600B1/en not_active IP Right Cessation
- 1983-02-03 BG BG062837A patent/BG42005A3/xx unknown
- 1983-02-03 EP EP83101036A patent/EP0085959B1/en not_active Expired
- 1983-02-03 BG BG062835A patent/BG41821A3/xx unknown
- 1983-02-03 DK DK043683A patent/DK164662C/da active Protection Beyond IP Right Term
- 1983-02-03 AU AU10982/83A patent/AU555083B2/en not_active Expired
- 1983-02-03 BG BG059592A patent/BG42185A3/xx unknown
- 1983-02-04 CA CA000420912A patent/CA1249830A/en not_active Expired
- 1983-02-04 DD DD83247730A patent/DD209446A5/de not_active IP Right Cessation
- 1983-06-20 ES ES523417A patent/ES523417A0/es active Granted
- 1983-06-20 ES ES523414A patent/ES523414A0/es active Granted
- 1983-06-20 ES ES523415A patent/ES523415A0/es active Granted
- 1983-06-20 ES ES523416A patent/ES523416A0/es active Granted
- 1983-06-20 ES ES523418A patent/ES523418A0/es active Granted
- 1983-10-17 SU SU833652410A patent/SU1301312A3/ru active
1986
- 1986-04-03 IL IL78419A patent/IL78419A0/xx unknown
1987
- 1987-03-30 KR KR1019870003071A patent/KR870001915B1/ko not_active Expired
- 1987-03-30 KR KR1019870003074A patent/KR870001918B1/ko not_active Expired
- 1987-03-30 KR KR1019870003070A patent/KR870001927B1/ko not_active Expired
- 1987-03-30 KR KR1019870003072A patent/KR870001916B1/ko not_active Expired
- 1987-03-30 KR KR1019870003073A patent/KR870001917B1/ko not_active Expired
- 1987-10-16 NO NO874330A patent/NO172341C/no not_active IP Right Cessation
1988
- 1988-06-01 JP JP63135352A patent/JPS6479153A/ja active Granted
- 1988-08-23 CA CA000575487A patent/CA1275102A/en not_active Expired - Lifetime
1989
- 1989-04-18 JP JP1098616A patent/JPH01301661A/ja active Granted
1991
- 1991-12-13 SG SG1060/91A patent/SG106091G/en unknown
1992
- 1992-04-09 HK HK258/92A patent/HK25892A/en not_active IP Right Cessation
- 1992-04-20 UY UY23404A patent/UY23404A1/es not_active IP Right Cessation
- 1992-07-10 CY CY1627A patent/CY1627A/xx unknown
1993
- 1993-06-11 NL NL930057C patent/NL930057I2/nl unknown

Also Published As

Publication number	Publication date
NO830368L (no)	1983-08-05
NO162556C (no)	1990-01-17
NO874330D0 (no)	1987-10-16
PL140812B1 (en)	1987-05-30
NL930057I2 (nl)	1994-02-16
MC1498A1 (fr)	1983-11-17
DE3382321D1 (de)	1991-07-25
DK43683A (da)	1983-08-05
NO162556B (no)	1989-10-09
ES8500232A1 (es)	1984-10-01
ES8500234A1 (es)	1984-10-01
DK43683D0 (da)	1983-02-03
FI82450C (fi)	1991-03-11
PH21348A (en)	1987-10-13
YU22183A (en)	1986-02-28
KR870001915B1 (ko)	1987-10-22
ATE64596T1 (de)	1991-07-15
PL245843A1 (en)	1985-01-30
CA1275102C (pt)	1990-10-09
PL245841A1 (en)	1985-01-30
PL140811B1 (en)	1987-05-30
NO874330L (no)	1983-08-05
DK164662C (da)	1992-12-14
ES8403872A1 (es)	1984-04-01
ES523417A0 (es)	1984-10-01
CY1627A (en)	1992-07-10
SU1301312A3 (ru)	1987-03-30
EP0249950A1 (en)	1987-12-23
JPH0251897B2 (pt)	1990-11-08
BG42003A3 (en)	1987-09-15
NZ203171A (en)	1986-12-05
IE54600B1 (en)	1989-12-06
PL245842A1 (en)	1985-01-30
IL78419A (en)	1989-01-31
EP0249950B1 (en)	1991-06-19
ES8500235A1 (es)	1984-10-01
NO172341B (no)	1993-03-29
FI82450B (fi)	1990-11-30
IL78419A0 (en)	1986-08-31
EP0085959A2 (en)	1983-08-17
DK164662B (da)	1992-07-27
KR870001917B1 (ko)	1987-10-22
KR880001466B1 (ko)	1988-08-11
DE3379654D1 (en)	1989-05-24
SI8310221A8 (en)	1995-10-31
JPH0468B2 (pt)	1992-01-06
BG42185A3 (en)	1987-10-15
IL67829A0 (en)	1983-06-15
ES523418A0 (es)	1984-10-01
PT76192B (en)	1986-01-24
BG41821A3 (en)	1987-08-14
GR77407B (pt)	1984-09-13
PL245845A1 (en)	1985-01-30
AU555083B2 (en)	1986-09-11
JPH01301661A (ja)	1989-12-05
PL240412A1 (en)	1985-01-30
ES8500233A1 (es)	1984-10-01
NL930057I1 (nl)	1993-09-01
FI830380A0 (fi)	1983-02-03
UY23404A1 (es)	1992-10-19
CA1249830A (en)	1989-02-07
NO172341C (no)	1993-07-07
HK25892A (en)	1992-04-16
ES523415A0 (es)	1984-10-01
BG42004A3 (en)	1987-09-15
PL140708B1 (en)	1987-05-30
KR870001927B1 (ko)	1987-10-22
CA1275102A (en)	1990-10-09
GB2114565B (en)	1985-06-26
EP0085959B1 (en)	1989-04-19
ES519491A0 (es)	1984-04-01
PL140809B1 (en)	1987-05-30
KR840003628A (ko)	1984-09-15
BG41822A3 (en)	1987-08-14
BG42005A3 (en)	1987-09-15
FI830380L (fi)	1983-08-05
ES8500231A1 (es)	1984-10-01
PL245844A1 (en)	1985-01-30
EP0085959A3 (en)	1984-07-18
PL141639B1 (en)	1987-08-31
GB2114565A (en)	1983-08-24
KR870001916B1 (ko)	1987-10-22
IE830213L (en)	1983-08-04
CS235306B2 (en)	1985-05-15
JPS6479153A (en)	1989-03-24
PT76192A (en)	1983-03-01
ES523416A0 (es)	1984-10-01
KR870001918B1 (ko)	1987-10-22
ATE42282T1 (de)	1989-05-15
ES523414A0 (es)	1984-10-01
YU44821B (en)	1991-02-28
SG106091G (en)	1992-03-20
HU189223B (en)	1986-06-30
AU1098283A (en)	1983-08-11
PL140810B1 (en)	1987-05-30
DD209446A5 (de)	1984-05-09
GB8302971D0 (en)	1983-03-09

Legal Events

Date	Code	Title
1997-06-10	KB	Patent renewed
2001-06-14	KB	Patent renewed
2003-05-29	EXP	Patent expired